CHEST 2023 On Demand Pass-Approach to CTD-ILD and IPAF: The Rheumatologist, Radiologist, and Pathologist Perspectives

Approach to CTD-ILD and IPAF: The Rheumatologist, Radiologist, and Pathologist Perspectives

Video Transcription

Video Summary

In this video, the speakers discuss the importance of recognizing connective tissue disease-associated interstitial lung disease (CTD-ILD). They explain that CTD-ILD is treatable and improving outcomes for patients requires early recognition and appropriate management. The speakers review the various patterns of interstitial lung disease seen in CTD, such as usual interstitial pneumonia (UIP) in rheumatoid arthritis, and non-specific interstitial pneumonia (NSIP) in systemic sclerosis and myositis. They also discuss the role of surgical lung biopsy in diagnosing CTD-ILD and guiding treatment decisions. The speakers highlight the need for a multidisciplinary approach, involving pulmonologists, rheumatologists, and radiologists, to accurately diagnose and manage CTD-ILD. They emphasize the importance of close collaboration between specialties in order to improve outcomes for patients with this condition. Ultimately, the goal is to recognize and treat CTD-ILD to extend life and improve quality of life for patients.

Meta Tag

Category Diffuse Lung Disease

Session ID 1087

Speaker Jonathan Chung

Speaker Andrew Churg

Speaker Rachana Krishna

Speaker Erin Wilfong

Track Diffuse Lung Disease

Keywords

CTD-ILD

treatable

improving outcomes

early recognition

usual interstitial pneumonia

non-specific interstitial pneumonia

surgical lung biopsy

multidisciplinary approach

improve quality of life